Abstract
The economic evaluation of health technologies has become a major tool in health policy in Europe for prioritizing the allocation of health resources and the approval of new technologies. The objective of this proposal was to develop guidelines for the economic evaluation of health technologies in Spain. A group of researchers specialized in economic evaluation of health technologies developed the document reported here, following the initiative of other countries in this framework, to provide recommendations for the standardization of methodology applicable to economic evaluation of health technologies in Spain. Recommendations appear under 17 headings or sections. In each case, the recommended requirements to be satisfied by economic evaluation of health technologies are provided. Each recommendation is followed by a commentary providing justification and compares and contrasts the proposals with other available alternatives. The economic evaluation of health technologies should have a role in assessing health technologies, providing useful information for decision making regarding their adoption, and they should be transparent and based on scientific evidence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Notes
Germany, Australia, Canada, Spain (previous proposal), the United States of America, France, Netherlands, Hungary, England and Wales, Ireland, Italy, Norway, Sweden, and Switzerland.
Acknowledgments
This work was funded by the Spanish Ministry of Health and Social Policy. We are grateful for the collaboration of M Alós (Hospital de Castellón), G Ariza (Agencia Laín Entrago), X Badía (IMS Health), JA Blasco (Agencia Laín Entrago), J Belaza (Boston), E Bernal (Instituto Aragonés de Ciencias de la Salud), L Betegón (Sanofi-Aventis), Ll Bohigas (Generalitat de Catalunya.), M Brosa (Oblikue), J Cabasés (Universidad Pública de Navarra), R Cabrera (Swedish Orphan A/S), D Casado (Universitat Pompeu Fabra), MA Casado (PORIB), D Callejo (Agencia Laín Entrago), B Corbacho (AETSA), F Cots (Hospital del Mar), T Dilla (Lilly), MD Estrada (AATRM), A Echevarría (Sanofi-Aventis), D Epstein (University of York), O Espallardo (Merck-Serono), J Espín (EASP), J Espinàs (SEMFYC), P Fernández-Cano (MSD), M Figueras (Novartis), S Flores (AETSA), MD Fraga (Hospital La Mancha-Centro), JM Freire (Escuela Nacional de Sanidad), L García (EASP), P Gómez (AETS), B González (Universidad de Las Palmas de Gran Canaria), MA Gutiérrez (OSTEBA), I Imaz (AETS), A Infante (Ministerio de Sanidad y Consumo), JL Lapuente (OSTEBA), J Llano (Fundación Gaspar Casal), R López (Ministerio de Sanidad y Consumo), M López-Argumedo (OSTEBA), S Márquez (AETSA), C Martín (Agencia Laín Entrago), J Martín (Universidad de Granada), F Martos (Universidad de Malaga), G Oliva (AATRM), A Ruano (AVALIA-T), A Ortega (Universidad de Navarra), V Ortún (Universidad Pompeu Fabra), R Orueta (SEMFYC), S Peiró (Escola Valenciana d’Estudis de la Salut), I Pérez (GSK), JL Pinto (Universidad Pablo de Olavide), C Piñol (Bayer), C Polanco (IMS Health), F Puigventós (Hospital Son Dureta), JM Rodríguez (Medtronic), J Rovira (Universidad de Barcelona), J Rejas (Pfizer), O Rivero (Oxford University), C Rubio (HEOR Consulting), S Rubio (Escuela Nacional de Sanidad), G de Rus (Universidad de Las Palmas de Gran Canaria), JA Sacristán (Lilly), PL Sánchez (Farmaindustria), A Ruano (AVALIA-T), V Sarmiento (AETSA), J Soto (Pfizer), J Vilaseca (SEMFYC). Special thanks are extended to Susana Melany Worbes for her review of the economic evaluation guidelines and to Pedro Serrano Aguilar (Canary Islands Health Services) for his constant support and encouragement.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is a reduced version in English of the original Spanish document. This extended version can be found in a book published by the Spanish Ministry of Health and an article was also published in the Spanish journal Gaceta Sanitaria. Additional information on the literature used and on the processes can be provided by the authors upon request.
Rights and permissions
About this article
Cite this article
López-Bastida, J., Oliva, J., Antoñanzas, F. et al. Spanish recommendations on economic evaluation of health technologies. Eur J Health Econ 11, 513–520 (2010). https://doi.org/10.1007/s10198-010-0244-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-010-0244-4